Rizatriptan has central antinociceptive effects against durally evoked responses

European Journal of Pharmacology

Volumn 328, Issue 1, 1997, Pages 37-40

  Cumberbatch, Michael J ^a   Hill, Raymond G ^a   Hargreaves, Richard J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(1B 1D) receptor agonist; Electrophysiology; Migraine; Rizatriptan; Trigeminal nucleus caudalis

Indexed keywords

RIZATRIPTAN; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030914002     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83024-5     Document Type: Article

References (22)

1. Arvieu L., Mauborgne S.B., Oliver C., Feltz P., Hamon M., Cesselin F. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. NeuroReport. 7:1996;1973-1976.
2. Bouchelet I., Cohen Z.V.I., Case B., Séguéla P., Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol. 50:1996;213-223.
3. Bove G., Moskowitz M.A. Electrophysiological evidence that meningeal afferents are nociceptive. Soc. Neurosci. Abstr. 21:1995;454.3.
4. 1B receptor messenger mRNA in neurones of the rat trigeminal ganglia. Eur. J. Pharmacol. 227:1992;357-359.
5. Cooper, B.Y., Sessle, B.J., 1993. Physiology of nociception in the trigeminal system. In: Olsen, J., Tfelt-Hansen, P., Welch, K.M.A. (Eds.), The Headaches. Raven Press, New York, NY, pp. 87-92.
6. 1D autoreceptors. Br. J. Pharmacol. 114:1995;1107-1109.
7. Goadsby P.J., Hoskin K.L. Inhibition of trigeminal neurones by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain. 67:1996;355-359.
8. Hargreaves, R.J., Williamson, D.J., Hill, R.G., Shepheard, S.L., 1997. Rizatriptan inhibits neurogenic dural vasodilatation - an intravital microscope study in rats. Proceedings of the 49th Meeting of the American Academy of Neurology, P01.134.
9. Kaube H., Hoskin K.L., Goadsby P.J. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br. J. Pharmacol. 109:1993;788-792.
10. Kaube H., Keay K.A., Hoskin K.L., Bandler R., Goadsby P.J. Expression of c-fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 629:1993;95-102.
11. Longmore, J., Razzaque, Z., Schofield, W.M., Boulanger, C.M., Taylor, A.A., Ferro, A., Brown, M.J., Pickard, J., Hill, R.G., Hargreaves, R.J., 1997. Rizatriptan shows craniovascular selectivity for human isolated middle meningeal over coronary arteries - a comparison with sumatriptan. Proceedings of the 49th Meeting of the American Academy of Neurology, P01.133.
12. 3H]sumatriptan binding in cat brain stem and spinal cord. Eur. J. Pharmacol. 280:1995;175-178.
13. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13:1992;307-311.
14. O'Shaughnessy C.T., Connor H.E., Fenuik W. Extracellular recordings of membrane potentials from guinea-pig isolated trigeminal ganglion: lack of effect of sumatriptan. Cephalalgia. 13:1993;175-179.
15. Rebeck G.W., Maynard K.J., Hyman B.T., Moskowitz M.A. Selective 5-HT1D-alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc. Natl. Acad. Sci. USA. 91:1994;3666-3669.
16. 1D receptor agonist MK-462 in vivo. Porceedings of the 3rd IUPHAR Meeting on Serotonin.
17. Shepheard S.L., Williamson D.J., Williams J., Hill R.G., Hargreaves R.J. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
18. Strassman A.M., Mason M., Moskowitz M.A., Maciewicz R. Response of trigeminal neurons to electrical stimulation of the dura. Brain Res. 379:1986;242-250.
19. Strassman A.M., Mineta Y., Vos B.P. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J. Neurosci. 14:1994;3725-3735.
20. Strassman A.M., Raymond S.A., Burstein R. Electrophysiological characterization of trigeminal ganglion cells that innervate intracranial dural venous sinuses in the rat. Soc. Neurosci. Abstr. 21:1995;454.5.
21. Visser W.H., Terwindt G.M., Reines S.A., Jiang K., Lines C.R., Ferrari M.D. Rizatriptan vs. sumatriptan in the acute treatment of migraine. Arch. Neurol. 53:1996;1132-1137.
22. Zemlan F.P., Behbehani M.M., Murphy R.M. Serotonin receptor subtypes and the modulation of pain transmission. Prog. Brain Res. 77:1988;349-355.